Dr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed for both non-squamous ...
A phase 2/3 study of EIK1001 in combination with pembrolizumab and chemotherapy in participants with stage 4 non–small cell lung cancer (NSCLC) (TeLuRide-008). This is an ASCO Meeting Abstract from ...
Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results